Barcelona 2013
Barcelona 2013
Abstract book - Abstract - 126
Go Back

Menu

AIDSImpact.com
Conference Details
Authors
International Committee
Plenary Speakers
Presenting Speakers
Programme
Sessions
Scientific Committee
Acknowledgements
Abstract #126  -  E-Posters English
Session:
  50.24: E-Posters English (Poster) on Sunday   in  Chaired by
Authors:
  Presenting Author:   Mr Dominic W. Makawiti - Children of God Relief CoGRI, Kenya
 
  Additional Authors:  Dr. Jordi Casabona, Sra Cristina Sanclemente, Dra. Anna  Esteve, Dra. Victoria Gonzalez, Grupo HIVITS TS,  
Aim:
To raise awarennes about the challenge in Kenya is the cost of genotypic testing, in particular, the reagents, which puts access totally beyond the reach of the ordinary citizen.
 
Method / Issue:
Nyumbani Diagnostic Laboratory (NDL), awaiting ISO 15189 accreditation, has been, over the past 15 years, core in the management of over 10,000 children perinatally infected with HIV. The children are cared for either in a residential facility, or through a community-based program. Founded in 1998, NDL has developed from providing CD4 and viral load testing in the beginning to offering genotypic testing for HIV drug resistance since 2010 and is the first and only Diagnostic Laboratory offering this service in Kenya. Access to resistance testing for the children began in 2005 through a collaboration with Kanazawa University, Japan. Genotypic testing for HIV drug resistance has now made it possible to move from blind prescription of antiretroviral (ARV) medication to informed prescription with resultant improved health for the children and regimen longevity. With the possibility of an already resistant virus being transmitted, informed prescription of ARV regimens is crucial. The challenge in Kenya is the cost of genotypic testing, in particular, the reagents, which puts access totally beyond the reach of the ordinary citizen.
 
Results / Comments:
Exchange knowledge, experiences and know how practices on methods forHIV diagnosis and treatment used all around the world to identify best practices.
 
Discussion:
Exchange knowledge, experiences and reflections on existing quality policies for HIV Diagnosis and Research Laboratories, the Organization of services provided and alternatives as well as experiences of training of human resources to perform up to the highest international standards.
 
Go Back

  Disclaimer   |   T's & C's   |   Copyright Notice    www.AIDSImpact.com www.AIDSImpact.com
ਊਊਊ